Suppr超能文献

用于特应性皮炎管理的保湿剂与当前及下一代屏障修复疗法对比

Moisturizers versus Current and Next-Generation Barrier Repair Therapy for the Management of Atopic Dermatitis.

作者信息

Elias Peter M, Wakefield Joan S, Man Mao-Qiang

出版信息

Skin Pharmacol Physiol. 2019;32(1):1-7. doi: 10.1159/000493641. Epub 2018 Oct 18.

Abstract

We compare here the principal characteristics of over-the-counter moisturizers with physiologic lipid-based barrier repair therapy. Moisturizers are standard ancillary therapy for anti-inflammatory skin disorders, like atopic dermatitis (AD), and can attenuate the emergence of AD, the initial step in the "atopic march." But not all moisturizers are beneficial; some can make skin function worse, and can even induce inflammation, possibly accounting for the frequent occurrence of "sensitive skin" in women. In contrast, physiologic lipid-based barrier repair therapy, if comprised of the 3 key stratum corneum lipids, in sufficient quantities and at an appropriate molar ratio, can correct the barrier abnormality and reduce inflammation in AD, and perhaps in other inflammatory dermatoses.

摘要

我们在此比较非处方保湿剂与基于生理脂质的屏障修复疗法的主要特征。保湿剂是用于治疗如特应性皮炎(AD)等抗炎性皮肤病的标准辅助疗法,并且可以减轻AD的出现,这是“特应性进程”的第一步。但并非所有保湿剂都是有益的;有些会使皮肤功能变差,甚至会引发炎症,这可能是女性中“敏感性皮肤”频繁出现的原因。相比之下,基于生理脂质的屏障修复疗法,如果由3种关键的角质层脂质组成,且数量充足、摩尔比合适,则可以纠正屏障异常并减轻AD以及或许其他炎性皮肤病中的炎症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验